Imatinib Available Phase N/A Trials for Chronic Myeloid Leukemia (CML)

IndicationsStatusPurposePhase
AvailableNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT00854841The Randomized Study of Dasatinib and High-Dose Imatinib (600mg) in Suboptimal Responder